PMID: 7023225Aug 1, 1981Paper

Role of blood platelets and prostaglandins in coronary artery disease

The American Journal of Cardiology
J Mehta, P Mehta

Abstract

In the last decade, several studies evaluating blood platelet function in patients with coronary heart disease have been reported. Although several platelet function abnormalities such as enhanced platelet aggregation, decreased platelet survival and increase in platelet release reaction in the stable condition and during stress in patients with myocardial ischemia have been recognized, the mechanism of these abnormalities is just beginning to be understood. Discovery of certain platelet and endothelium-generated prostaglandins has provided some information as to the possible mechanism of platelet dysfunction. Abnormalities of prostaglandin production and platelet sensitivity to various prostaglandins may have an important bearing on the enhanced platelet aggregation in vivo, genesis of atherosclerosis and probably precipitation of acute ischemic events. Since the discovery of these prostaglandins, the precise mode of action of several commonly used platelet-active drugs has been clarified. Development of new drugs acting at selective steps in the prostaglandin pathways may provide some exciting novel therapeutic procedures in patients with coronary heart disease.

References

Mar 1, 1977·Circulation Research·W I Rosenblum, F El-Sabban
May 18, 1978·The New England Journal of Medicine·P Needleman, G Kaley
May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Borgeat, B Samuelsson
Jul 1, 1979·Stroke; a Journal of Cerebral Circulation·P Mehta, J Mehta
Feb 20, 1978·JAMA : the Journal of the American Medical Association·J W DavisC R Hartman
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Nov 1, 1975·Thrombosis Research·S R Saba, R G Mason
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·R RossL A Harker
Dec 1, 1973·Circulation·P P SteeleE Genton
Feb 21, 1974·The New England Journal of Medicine·A C CarvalhoR S Lees
Feb 1, 1970·The Journal of Clinical Investigation·R L NachmanB Ferris
Apr 28, 1972·Nature·R I Hawkins
Oct 1, 1973·The American Journal of Cardiology·N Salky, M Dugdale
May 1, 1972·British Heart Journal·J R Hampton, R Gorlin
Jul 1, 1968·Journal of Atherosclerosis Research·A PoplawskiS Niewiarowski
Feb 1, 1981·Circulation·M SobelG Kurland
Feb 1, 1981·The American Journal of Cardiology·J Mehta, P Mehta
Feb 15, 1980·JAMA : the Journal of the American Medical Association
Mar 29, 1980·British Medical Journal·D P Mikhailidis, P Dandona
Aug 1, 1980·Science·I D GoldbergR I Handin
Feb 1, 1981·Annals of Internal Medicine·P B Oliva
Feb 1, 1980·The Journal of Pediatrics·P Mehta, J Mehta
Jan 12, 1980·British Medical Journal·S HeptinstallJ R Mitchell
May 1, 1980·Prostaglandins·T J Williams, P J Piper

Citations

Jan 1, 1987·Basic Research in Cardiology·G J Grover, H R Weiss
Oct 15, 1982·European Journal of Pharmacology·K M MullaneS Moncada
Apr 15, 1987·Thrombosis Research·G G Neri SerneriG F Gensini
May 1, 1984·Prostaglandins·B Rosenkranz, J C Frölich
Jan 20, 1995·Journal of the Autonomic Nervous System·Z Li, M W Chapleau
Aug 1, 1982·Prostaglandins, Leukotrienes, and Medicine·P Mehta, J Mehta
Sep 1, 1983·Prostaglandins, Leukotrienes, and Medicine·J MehtaN Ostrowski
Feb 1, 1985·Prostaglandins, Leukotrienes, and Medicine·M L Dahl, P Uotila
Mar 1, 1985·Prostaglandins, Leukotrienes, and Medicine·H SinzingerB A Peskar
Jan 1, 1986·Prostaglandins, Leukotrienes, and Medicine·J MehtaW W Nichols
Sep 1, 1986·Prostaglandins, Leukotrienes, and Medicine·H SinzingerB A Peskar
Oct 1, 1983·Journal of the American College of Cardiology·J MehtaL Brigmon
Mar 10, 1994·The American Journal of Cardiology·J G DiodatiA A Quyyumi
Dec 18, 1990·The American Journal of Cardiology·W W Parmley
Feb 1, 1987·Thrombosis Research·J MehtaM B Ward
Apr 1, 1985·American Heart Journal·M UgarteV Martín-Júdez
Oct 1, 1991·The American Journal of Cardiology·E J VasilievaI A Bespalko
Apr 9, 2005·Clinical Cardiology·Mustafa GökçeMehmet Küçükosmanoğlu
Jun 1, 1983·Journal of the American College of Cardiology·J L RouleauR J Havel
Mar 1, 1987·British Journal of Urology·M S BornmanD J du Plessis
Jan 1, 1985·Catheterization and Cardiovascular Diagnosis·R A StineD V Unverferth
Dec 1, 1986·Circulation Research·M A Young, S F Vatner
Jun 1, 1986·Hypertension·A W Ford-Hutchinson, G Letts
Oct 3, 2002·Current Opinion in Cardiology·Paulette Mehta
Dec 1, 1990·The Journal of Urology·S C KimY J Cha
Sep 27, 2000·Biochimica Et Biophysica Acta·C NoulaA Nicolaou
Nov 26, 1993·The American Journal of Cardiology·B R LucchesiA C Uprichard

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.